Lung cancer incidence in never smokers

被引:5
|
作者
Wakelee, Heather A.
Chang, Ellen T.
Gomez, Scarlett L.
Keegan, Theresa H.
Feskanich, Diane
Clarke, Christina A.
Holmberg, Lars
Yong, Lee C.
Kolonel, Laurence N.
Gould, Michael K.
West, Dee W.
机构
[1] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[3] No Calif Canc Ctr, Fremont, CA USA
[4] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[5] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Ctr Dis Control & Prevent, Div Surveillance Hazard Evaluat & Field Studies, Natl Inst Occupat Safety & Hlth, Cincinnati, OH USA
[8] Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA
[9] Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Lung cancer is a leading cause of cancer death worldwide. Although smoking remains the predominant cause of lung cancer, lung cancer in never smokers is an increasingly prominent public health issue. However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited. Methods We reviewed the existing literature on lung cancer incidence and mortality rates among never smokers and present new data regarding rates in never smokers from the following large, prospective cohorts: Nurses' Health Study; Health Professionals Follow-Up Study; California Teachers Study; Multiethnic Cohort Study; Swedish Lung Cancer Register in the Uppsala/Orebro region; and First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Results Truncated age-adjusted incidence rates of lung cancer among never smokers age 40 to 79 years in these six cohorts ranged from 14.4 to 20.8 per 100,000 person-years in women and 4.8 to 13.7 per 100,000 person-years in men, supporting earlier observations that women are more likely than men to have non-smoking-associated lung cancer. The distinct biology of lung cancer in never smokers is apparent in differential responses to epidermal growth factor receptor inhibitors and an increased prevalence of adenocarcinoma histology in never smokers. Conclusion Lung cancer in never smokers is an important public health issue, and further exploration of its incidence patterns, etiology, and biology is needed.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 50 条
  • [1] COPD and lung cancer incidence in never smokers
    Park, Hye Yun
    Shin, Sun Hye
    Kang, Danbee
    Yoo, Kwang Ha
    Rhee, Chin Kook
    Lim, Seong Yong
    Suh, Gee Young
    Kim, Hojoong
    Cho, Juhee
    Kwon, O. Jung
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Lung cancer incidence in never smokers: Genetic and gender basis
    Peddireddy, Vidyullatha
    [J]. GENE REPORTS, 2016, 4 : 198 - 207
  • [4] Lung cancer in never smokers
    Torok, Szilvia
    Hegedus, Balazs
    Laszlo, Viktoria
    Hoda, Mir Alireza
    Ghanim, Bahil
    Berger, Walter
    Klepetko, Walter
    Dome, Balazs
    Ostoros, Gyula
    [J]. FUTURE ONCOLOGY, 2011, 7 (10) : 1195 - 1211
  • [5] Lung cancer in never smokers
    Ostoros, Gyula
    Torok, Szilvia
    [J]. LUNG CANCER, 2012, 77 : S12 - S13
  • [6] Lung Cancer in Never Smokers
    Yang, Ping
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 32 (01) : 10 - 21
  • [7] Lung Cancer in Never Smokers
    Rivera, Gabriel Alberto
    Wakelee, Heather
    [J]. LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 : 43 - 57
  • [8] Is the Incidence of Adenocarcinoma of the Lung Rising in Never Smokers?
    Samet, Jonathan M.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (07)
  • [9] LUNG CANCER IN NEVER-SMOKERS
    Naito, Y.
    Kubota, K.
    Ohe, Y.
    Niho, S.
    Ohmatsu, H.
    Goto, K.
    Yoh, K.
    Nishijima, N.
    Nagai, K.
    Nishiwaki, Y.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 127 - 127
  • [10] Primary lung cancer in never smokers
    Maehara, Yoshihiko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (04) : 285 - 286